Breast Lesion Localization Methods Market

Breast Lesion Localization Methods Market by Type (Wire, Radioisotope [Radio Occult], Magnetic), Usage (Tumor Identification, Sentinel Lymph Node [Lumpectomy]), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecast to 2024

Report Code: MD 4236 May, 2019, by marketsandmarkets.com
COVID-19

Get in-depth analysis of how COVID-19 is impacting the Breast Lesion Localization Methods Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Breast Lesion Localization Methods Market

Request Now

The breast lesion localization methods market is expected to grow from USD 413 million in 2018 to USD 598 million by 2024, at a CAGR of 6.3% during the forecast period. The growth of this market is primarily driven by factors such as the rising incidence of breast cancer, an increasing number of breast cancer surgeries, rising awareness of early detection of breast cancer. However, uncertainty in regulatory approval procedures is expected to restrain the growth of this market during the forecast period to a certain extent.

Breast Lesion Localization Methods Market

By type, the electromagnetic localization segment is expected to be the fastest-growing segment in the breast lesion localization methods market during the forecast period.

The electromagnetic localization segment is projected to grow at the highest CAGR between 2018 and 2024. Electromagnetic localization has the potential to reduce surgical delays, improve patient satisfaction, and optimize surgical planning, all without radioactive components. Due to their benefits, the demand for such advanced breast localization methods is expected to grow significantly in the coming years.

Breast Lesion Localization Methods Market

By usage, the sentinel lymph node identification segment is growing at the highest rate.

The sentinel lymph node identification segment is projected to grow at the highest rate in the market, by usage. This is attributed to the increasing acceptance of SLNB as a first-line diagnostic approach for breast cancer staging. Sentinel lymph node identification procedures are further divided into lumpectomy and mastectomy. The lumpectomy segment is projected to grow at the highest rate during the forecast period. Growth in this segment can be attributed to the increasing early-stage breast cancer diagnosis and the shift toward minimally invasive procedures.

Breast Lesion Localization Methods Market

The Asia Pacific accounted for the largest market share during the forecast period.

The breast lesion localization methods market is divided into four major regions-North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, Asia Pacific accounted for the largest share of this market, followed by Europe. The APAC market is projected to grow at the highest CAGR during the forecast period. Growth in this market can primarily be attributed to the rapidly increasing patient population, increasing healthcare expenditure, improving healthcare infrastructure, high government spending on breast cancer research, and increasing awareness about the importance of the early detection of breast cancer in several APAC countries.

Market Dynamics

Driver: Increasing number of breast cancer surgeries

Among the total population diagnosed with breast cancer (incident cases), around 80% undergoes surgeries per year. Similarly, among the prevalent cases (except incidence), approximately 30–35% of the patient population undergoes breast cancer surgeries every year. The growing number of breast cancer surgeries, coupled with the growing need for new, technologically advanced, and less expensive breast lesion localization methods, is expected to drive market growth in the coming years.

Restraint: uncertainty in regulatory approval

Regulatory agencies such as the US FDA require comprehensive clinical data supporting the clinical safety and efficacy of a product under approval. With the presence of stringent regulatory requirements for product approval, players operating in the breast lesion localization methods (specially radioisotope localization) market need to obtain nuclear regulatory clearance from the Nuclear Regulatory Commission to ensure the safe use of radioactive seeds. This approval process is very lengthy and capital-intensive, which makes it difficult for small manufacturers and companies with limited budgets to sustain in this market.

Opportunity:  increasing adoption of technologically advanced electromagnetic reflectors

The emergence of technologically advanced localization methods that use electromagnetic waves to localize breast lesions is another major development in this market. Cianna Medical (US) developed this technology and in December 2014, the company received FDA approval for the SAVI SCOUT surgical guidance system. This system uses electromagnetic reflectors to localize lesions. As of October 2018, SAVI SCOUT was used in more than 400 hospitals across the US, and more than 58,000 women have had a wire-free localization of breast tumors using it. SAVI SCOUT is an optimal addition to breast localization methods, and has the potential to reduce surgical delays, improve patient satisfaction, and optimize surgical planning, all without using radioactive components. These factors will help it capture a major share of the breast lesion localization methods market in the coming years.

Challenge: dearth of oncologists

Over the years, the incidence of breast cancer has increased significantly, and is expected to increase further in the coming years. However, there has not been a subsequent growth in the number of oncologists, and this situation is more pronounced in developing countries. According to data obtained from MIMS (Malaysia), in 2016, there was a dearth of oncologists in Malaysia and the situation is expected to worsen in the coming years as the number of cancer cases in the country is projected to increase by 54% by 2025. Similarly, in India, there were only 1,000 trained oncologists and their ratio to the number of patients was about 1:2,000 in 2014. This dearth of trained professionals is thus expected to hamper the growth of the breast lesion localization methods market during the forecast period.

Scope of the Report

Report Metric

Details

Market size available for years

2016–2024

Base year considered

2017

Forecast period

2018–2024

Forecast units

Volume (Million Procedures) and Values (USD Million)

Segments covered

On the basis of type, the breast lesion localization methods market is segmented as follows:

  • Wire Localization
  • Radioisotope Localization
    • Radioactive Seed Localization
    • Radioguided Occult Lesion Localization
  • Magnetic Localization
  • Electromagnetic Localization
  • Other Localization Methods (blue dye, optical fibers, charcoal aqueous suspension, and cryo-assisted localization)

On the basis of Usage, the breast lesion localization methods market is segmented as follows:

  • Tumor Identification
  • Sentinel Lymph Node Identification
    • Lumpectomy
    • Mastectomy

 

Geographies covered

  • North America
    • US
    • Canada
  • Europe
  • Asia Pacific
  • RoW

Companies covered

               
12 major players covered in total, including:
BD (US), Endomagnetics (UK), SOMATEX Medical Technologies (Germany), Cook Medical (US), Cianna Medical (US), Leica Biosystems (US), Health Beacon, Intra-Medical Imaging LLC, Isoaid, LLC, Surgiceye GmbH, and Ranfac Corporation

Key Market Players

BD (US), Endomagnetics (UK), SOMATEX Medical Technologies (Germany), Cook Medical (US), Cianna Medical (US), Leica Biosystems (US), Health Beacon (Ireland), Intra-Medical Imaging LLC (US), Surgiceye GmbH (Germany), and Ranfac Corporation (US)

Recent Developments

Product Launches

  • In 2017, BD Company acquired C.R. Bard to enter the market.
  • In 2017, Cianna Medical launched the SAVI SCOUT Reflector.
  • In 2017, Endomagnetics entered into a distribution agreement with Sysmex to distribute its Magseed product in Europe, the Middle East, and Africa
  • In 2017, Leica Biosystems acquired Devicor Medical Products to enter the market.

Critical questions the report answers:

  • Who are the major market players in the market?
  • What are the regional growth trends and the largest revenue-generating regions?
  • What are the major drivers and challenges in the market?
  • What are the major type segments in the market?
  • What are the major usage segments in the market?
  • What is the current end-user preference for localization devices, and what is the replacement trend in the market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Study Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology
    2.1 Research Design
    2.2 Market Breakdown and Data Triangulation
    2.3 Market Size Estimation 
    2.4 Primary Research (Interviews) – Sampling Frame 

3 Executive Summary

4 Market Overview
    4.1 Introduction
    4.2 Market Dynamics
           4.2.1 Drivers
                     4.2.1.1 Rising Incidence of Breast Cancer
                     4.2.1.2 Increasing Number of Breast Cancer Surgeries
                     4.2.1.3 Increasing Awareness on the Early Detection of Breast Cancer  
           4.2.2 Restraints
                     4.2.2.1 Uncertainty in Regulatory Approval Procedures
                     4.2.2.2 Visionary Leaders
           4.2.3 Opportunities
                     4.2.3.1 Increasing Adoption of Technologically Advanced Electromagnetic Reflectors
                     4.2.3.1 Dearth of Oncologists
           4.2.4 Challenges
                     4.2.4.1 Dearth of Oncologists

5 Breast Lesion Localization Methods Market, By Type, Million Procedures/USD Million (2016-2024)
    5.1 Introduction
    5.2 Wire Localization
    5.3 Radioisotope Localization 
           5.3.1 Radioguided Occult Lesion Localization
           5.3.2 Radioactive Seed Localization
    5.4 Electromagnetic Localization
    5.5 Magnetic Localization
    5.6 Other Localization Methods

6 Breast Lesion Localization Methods Market, By Usage, Million Procedures (2016-2024) 
    6.1 Introduction
    6.2 Tumor Identification
    6.3 Sentinel Lymph Node Identification
           6.3.1 Lumpectomy
           6.3.2 Mastectomy

7 Breast Lesion Localization Methods Market, By Technique, Million Procedures (2016-2024)
    7.1 Introduction
    7.2 Fine-Needle Aspiration Biopsy
    7.3 Core Needle Biopsy
    7.4 Image Guided Biopsy
    7.5 Surgical Biopsy

8 Breast Lesion Localization Methods Market, By Region, Million Procedures (2016-2024) 
    8.1 Introduction
    8.2 Asia Pacific 
           8.2.1 Market Estimates and Forecasts, By Country,  2016–2024
           8.2.2 Market Estimates and Forecasts, By Type,  2016–2024
           8.2.3 Market Estimates and Forecasts, By Usage,  2016–2024
           8.2.4 Market Estimates and Forecasts, By Technique,  2016–2024
                    8.2.4.1 US
                    8.2.4.1 Canada
    8.3 Europe
           8.2.1 Market Estimates and Forecasts, By Country,  2016–2024
           8.2.2 Market Estimates and Forecasts, By Type,  2016–2024
           8.2.3 Market Estimates and Forecasts, By Usage,  2016–2024
           8.2.4 Market Estimates and Forecasts, By Technique,  2016–2024
    8.4 North America
           8.2.1 Market Estimates and Forecasts, By Country,  2016–2024
           8.2.2 Market Estimates and Forecasts, By Type,  2016–2024
           8.2.3 Market Estimates and Forecasts, By Usage,  2016–2024
           8.2.4 Market Estimates and Forecasts, By Technique,  2016–2024
                     4.2.4.1 US
                     4.2.4.1 Canada
    8.5 Rest of the World
           8.2.1 Market Estimates and Forecasts, By Country,  2016–2024
           8.2.2 Market Estimates and Forecasts, By Type,  2016–2024
           8.2.3 Market Estimates and Forecasts, By Usage,  2016–2024
           8.2.4 Market Estimates and Forecasts, By Technique,  2016–2024

9 Competitive Landscape
    9.1 Overview
    9.2 Competitive Leadership Mapping
           9.2.1 Strength of Product Portfolio
           9.2.2 Business Strategy Excellence
    9.3 Competitive Scenario
    9.4 End User Preference Study 
           9.4.1 Breast Lesion Localization Methods: Comparative Analysis
           9.4.2 Breast Lesion Localization Methods: Selection Criteria Evaluation
           9.4.3 Qualitative Assessment of Replacement Trend

10 Company Profile
     10.1 Overview Argon Medical Devices
             10.1.1 Business Overview
             10.1.2 Product Offered
     10.2 B.D. Company
             10.2.1 Business Overview
             10.2.2 Becton Dickinson and Company: Company Snapshot (2018)
             10.2.3 Product Offered
             10.2.4 Recent Developments
     10.3 Cianna Medical
             10.3.1 Business Overview
             10.3.2 Merit Medical Systems, Inc: Company Snapshot (2018)
             10.3.3 Product Offered
             10.3.4 Recent Developments
     10.4 Cook Medical
             10.4.1 Business Overview
             10.4.2 Product Offered
     10.5 Endomagnetics Ltd
             10.5.1 Business Overview
             10.5.2 Product Offered
             10.5.3 Recent Developments
     10.6 Health Beacon
             10.6.1 Business Overview
             10.6.2 Product Offered
             10.6.3 Recent Developments
     10.7 Intra-Medical Imaging Llc
             10.7.1 Business Overview
             10.7.2 Product Offered
     10.8 Isoaid, Llc
             10.8.1 Business Overview
             10.8.2 Product Offered
     10.9 Leica Biosystems
             10.9.1 Business Overview
             10.9.2 Danaher: Company Snapshot (2018)
             10.9.3 Business Overview
             10.9.4 Recent Developments
     10.10 Somatex Medical Technologies GmbH
             10.10.1 Business Overview
             10.10.2 Product Offered
             10.10.3 Recent Developments
     10.11 Surgiceye GmbH 
           9.11.1 Business Overview
           9.11.2 Product Offered
     10.12 Ranfac Corporation
           9.12.1 Business Overview
           9.12.2 Product Offered

11 Appendix
     11.1 Discussion Guide
     11.2 Knowledge Store: Marketsandmarkets’ Subscription Portal 
     11.3 Introducing Rt: Real-Time Market Intelligence
     11.4 Available Customizations
     11.5 Related Reports
     11.6 Authors Details


List of Tables (67 Tables)

Table 1 Breast Lesion Localization Methods Market, By Type, 2016–2024 (Million Procedures)
Table 2 Breast Lesion Localization Methods Market, By Type, 2016–2024 (USD Million)
Table 3 Wire Localization Methods Market, By Region, 2016–2024 (Million Procedures)
Table 4 North America: Wire Localization Methods Market, By Country, 2016–2024 (Million Procedures)
Table 5 Wire Localization Market, By Region, 2016–2024 (USD Million)
Table 6 North America: Wire Localization Market, By Country, 2016–2024 (USD Million)
Table 7 Radioisotope Localization Methods Market, By Region, 2016–2024 (Million Procedures)
Table 8 North America: Radioisotope Localization Methods Market, By Country, 2016–2024 (Million Procedures)
Table 9 Radioisotope Localization Market, By Region, 2016–2024 (USD Million)
Table 10 North America: Radioisotope Localization Market, By Country, 2016–2024 (USD Million)
Table 11 Radioisotope Localization Market, By Product, 2016–2024 (Million Procedures)
Table 12 Radioisotope Localization Market, By Product, 2016–2024 (USD Million)
Table 13 Radioguided Occult Lesion Localization Market, By Region, 2016–2024 (Million Procedures)
Table 14 North America: Radioguided Occult Lesion Localization Market, By Country, 2016–2024 (Million Procedures)
Table 15 Radioguided Occult Lesion Localization Market, By Region, 2016–2024 (USD Million)
Table 16 North America: Radioguided Occult Lesion Localization Market, By Country, 2016–2024 (USD Million)
Table 17 Radioactive Seed Localization Market, By Region, 2016–2024 (Million Procedures)
Table 18 North America: Radioactive Seed Localization Market, By Country, 2016–2024 (Million Procedures)
Table 19 Radioactive Seed Localization Market, By Region, 2016–2024 (USD Million)
Table 20 North America: Radioactive Seed Localization Market, By Country, 2016–2024 (USD Million)
Table 21 Electromagnetic Localization Methods Market, By Region, 2016–2024 (Million Procedures)
Table 22 Electromagnetic Localization Methods Market, By Region, 2016–2024 (USD Million)
Table 23 Magnetic Localization Methods Market, By Region, 2016–2024 (Million Procedures)
Table 24 North America: Magnetic Localization Methods Market, By Country, 2016–2024 (Million Procedures)
Table 25 Magnetic Localization Methods Market, By Region, 2016–2024 (USD Million)
Table 26 North America: Magnetic Localization Methods Market, By Country, 2016–2024 (USD Million)
Table 27 Other Breast Lesion Localization Methods Market, By Region, 2016–2024 (Million Procedures)
Table 28 North America: Other Breast Lesion Localization Methods Market, By Country, 2016–2024 (Million Procedures)
Table 29 Other Breast Lesion Localization Methods Market, By Region, 2016–2024 (USD Million)
Table 30 North America: Other Breast Lesion Localization Methods Market, By Country, 2016–2024 (USD Million)
Table 31 Breast Lesion Localization Methods Market, By Usage, 2016–2024 (Million Procedures)
Table 32 Breast Lesion Localization Methods Market for Sentinel Lymph Node
Table 33 Breast Lesion Localization Methods Market for Sentinel Lymph Node
Table 34 Breast Lesion Localization Methods Market for Sentinel Lymph Node
Table 35 Sentinel Lymph Node Identification Market for Lumpectomy, By Region, 2016–2024 (Million Procedures)
Table 36 North America: Sentinel Lymph Node Identification Market for Lumpectomy, By Country, 2016–2024 (Million Procedures)
Table 37 Global Number of Mastectomy Procedures Per 10,000 Population, 2012–2024
Table 38 Sentinel Lymph Node Identification Market for Mastectomy, By Region, 2016–2024 (Million Procedures)
Table 39 North America: Sentinel Lymph Node Identification Market for Mastectomy, By Country, 2016–2024 (Million Procedures)
Table 40 Breast Lesion Localization Methods Market for Tumor Identification, By Region, 2016–2024 (Million Procedures)
Table 41 North America: Breast Lesion Localization Methods Market for Tumor Identification, By Country, 2016–2024 (Million Procedures)
Table 42 Breast Lesion Localization Methods Market, By Region, 2016–2024 (Million Procedures)
Table 43 Asia Pacific: Breast Lesion Localization Methods Market, By Type, 2016–2024 (Million Procedures)
Table 44 Asia Pacific: Radioisotope Localization Market, By Product, 2016–2024 (Million Procedures)
Table 45 Asia Pacific: Breast Lesion Localization Methods Market, By Usage, 2016–2024 (Million Procedures)
Table 46 Asia Pacific: Breast Lesion Localization Methods Market for Sentinel Lymph Node Identification, By Surgery Type, 2016–2024 (Million Procedures)
Table 47 Europe: Breast Lesion Localization Methods Market, By Type, 2016–2024 (Million Procedures)
Table 48 Europe: Radioisotope Localization Market, By Product, 2016–2024 (Million Procedures)
Table 49 Europe: Breast Lesion Localization Methods Market, By Usage, 2016–2024 (Million Procedures)
Table 50 Europe: Breast Lesion Localization Methods Market for Sentinel Lymph Node Identification, By Surgery Type, 2016–2024 (Million Procedures)
Table 51 North America: Breast Lesion Localization Methods Market, By Type, 2016–2024 (Million Procedures)
Table 52 North America: Radioisotope Localization Market, By Product, 2016–2024 (Million Procedures)
Table 53 North America: Breast Lesion Localization Methods Market, By Usage, 2016–2024 (Million Procedures)
Table 54 North America: Breast Lesion Localization Methods Market for Sentinel Lymph Node Identification, By Surgery Type, 2016–2024(Million Procedures)
Table 55 North America: Breast Lesion Localization Methods Market, By Country, 2016–2024 (Million Procedures)
Table 56 Us: Breast Lesion Localization Methods Market, By Type, 2016–2024 (Million Procedures)
Table 57 Us: Radioisotope Localization Market, By Product, 2016–2024 (Million Procedures)
Table 58 Us: Breast Lesion Localization Methods Market, By Usage, 2016–2024 (Million Procedures)
Table 59 Us: Breast Lesion Localization Methods Market for Sentinel Lymph Node Identification, By Surgery Type, 2016–2024 (Million Procedures)
Table 60 Canada: Breast Lesion Localization Methods Market, By Type, 2016–2024 (Million Procedures)
Table 61 Canada: Radioisotope Localization Market, By Product, 2016–2024 (Million Procedures)
Table 62 Canada: Breast Lesion Localization Methods Market, By Usage, 2016–2024 (Million Procedures)
Table 63 Canada: Breast Lesion Localization Methods Market for Sentinel Lymph Node Identification, By Surgery Type, 2016–2024 (Million Procedures)
Table 64 Row: Breast Lesion Localization Methods Market, By Type, 2016–2024 (Million Procedures)
Table 65 Row: Radioisotope Localization Market, By Product, 2016–2024 (Million Procedures)
Table 66 Row: Breast Lesion Localization Methods Market, By Usage, 2016–2024 (Million Procedures)
Table 67 Row: Breast Lesion Localization Methods Market for Sentinel Lymph Node Identification, By Surgery Type, 2016–2024 (Million Procedures)
 

List of Figures (9 Figures)

 
Figure 1 Breast Lesion Localition Methods Market, By Type (Million Procedures)
Figure 2 Radioisotopes Localization Market, By Product (Million Procedures)
Figure 3 Breast Lesion Localition Methods Market, By Usgae (Million Procedures)
Figure 4 Sentinel Lymph Node Identification Market, By Surgery Type (Million Procedures)
Figure 5 Breast Lesion Localition Methods Market, By Region (Million Procedures)
Figure 6 Global Incidence of Breast Cancer, 2012–2025
Figure 7 Estimation of Breast Cancer Surgeries (US & Outside Us), 2012–2024
Figure 8 Reimbursement for Breast Lesion Localization Device Placement, 2014–2018
Figure 9 Breast Lesion Localization Methods Market (Global), Competitive Leadership Mapping, 2018

This study involved four major activities in estimating the current market size for breast lesion localization method. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the number of breast lesion localization procedures and the value market. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Factors such as the global breast cancer population, percentage splits of palpable and non-palpable breast lesions, early and late-stage diagnosis, the number of breast cancer surgeries, and the cost of localization devices in various regions were studied through primary and secondary research to arrive at the global breast lesion localization methods value market (USD million) and volume market (million procedures). Secondary research included the study of the annual and financial reports of top market players, presentations, websites, and press releases of top players, news articles, journals; and paid databases, white papers, medical journals, certified publications, articles from recognized authors, directories, and databases such as Centers for Disease Control and Prevention (CDC), National Breast and Cervical Cancer Early Detection Program (NBCCEDP), World Health Organization (WHO), Organization for Economic Co-operation and Development (OECD), National Center for Biotechnology Information (NCBI), GLOBOCAN, International Agency for Research on Cancer, American College of Radiology (ACR), American Cancer Society (ACS), and European Institute of Oncology (IEO).

Primary research included extensive interviews with key opinion leaders such as CEOs, vice presidents, directors, marketing executives, and related key executives from various companies. The percentage splits, shares, and breakdowns of the segments were determined using secondary sources and verified through primary sources. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.

Primary Research

The breast lesion localization methods market comprises several stakeholders such as raw material suppliers, manufacturers of breast lesion localization devices, and regulatory organizations in the supply chain. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The primary interviewees from the demand side include professionals such as medical oncologists, medical directors and breast surgeons from hospitals, breast imaging medical centers, cancer research centers and institutes, medical schools and universities, clinical research organizations, and physicians in diagnostic centers. The primary sources from the supply side include key opinion leaders, distributors, and breast lesion localization device manufacturers.

Market Size Estimation

Both the top-down and bottom-up approaches were used to estimate and validate the total size of the breast lesion localization methods market (in terms of value and volume). These approaches were also used extensively to estimate the size of various subsegments in the market. After arriving at the overall market size-using the market size estimation processes explained above-the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides of the breast lesion localization methods industry.

Breast Lesion Localization Methods Market

To know about the assumptions considered for the study, download the pdf brochure

Report Objectives

  • To define, describe, and forecast the breast lesion localization methods market on the basis of type, usage, and region.
  • To provide detailed information on the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges).
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market.
  • To forecast the market size of segments with respect to North America, Europe, Asia Pacific and the Rest of the World (RoW).
  • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies.
  • To track and analyze competitive developments (such as acquisitions, product launches, partnerships, and agreements) in the breast lesion localization methods market
  • To evaluate the different parameters considered for the selection of breast lesion localization.
  • To study end-user preferences for different breast lesion localization methods and the replacement trend and buying behavior of end users.

Available Customizations

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

The following customization options are available for the report:

Regional Analysis

  • Further breakdown of the European market into Germany, France, UK, Italy, Spain, and the Rest of Europe (RoE)
  • Further breakdown of the Asia Pacific market into China, India, Japan, South Korea, Australia, and others
Report Code
MD 4236
Published ON
May, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Breast Lesion Localization Methods Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home